SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells

Detalhes bibliográficos
Autor(a) principal: Ribeiro, Ana Sofia
Data de Publicação: 2018
Outros Autores: Nobre, Ana Rita, Mendes, Nuno, Almeida, João, Vieira, André Filipe, Sousa, Bárbara, Carvalho, Filomena Almeida, Monteiro, Joana, Polónia, António, Fonseca, Martina, Sanches, João Miguel, Santos, Nuno C., Seruca, Raquel, Paredes, Joana
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/37707
Resumo: © The Author(s). 2018. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
id RCAP_e0a4ca43b6563205a93ae519abd98625
oai_identifier_str oai:repositorio.ul.pt:10451/37707
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cellsP-cadherinDasatinibBasal-like breast cancerSrc family kinase© The Author(s). 2018. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.BACKGROUND: Basal-like breast cancer (BLBC) is a poor prognosis subgroup of triple-negative carcinomas that still lack specific target therapies and accurate biomarkers for treatment selection. P-cadherin is frequently overexpressed in these tumors, promoting cell invasion, stem cell activity and tumorigenesis by the activation of Src-Family kinase (SRC) signaling. Therefore, our aim was to evaluate if the treatment of BLBC cells with dasatinib, the FDA approved SRC inhibitor, would impact on P-cadherin induced tumor aggressive behavior. METHODS: P-cadherin and SRC expression was evaluated in a series of invasive Breast Cancer and contingency tables and chi-square tests were performed. Cell-cell adhesion measurements were performed by Atomic Force Microscopy, where frequency histograms and Gaussian curves were applied. 2D and 3D cell migration and invasion, proteases secretion and self-renew potential were evaluated in vitro. Student's t-tests were used to determine statistically significant differences. The cadherin/catenin complex interactions were evaluated by in situ proximity-ligation assay, and statistically significant results were determined by using Mann-Whitney test with a Bonferroni correction. In vivo xenograft mouse models were used to evaluate the impact of dasatinib on tumor growth and survival. ANOVA test was used to evaluate the differences in tumor size, considering a confidence interval of 95%. Survival curves were estimated by the Kaplan-Meier's method, using the log-rank test to assess significant differences for mice overall survival. RESULTS: Our data demonstrated that P-cadherin overexpression is significantly associated with SRC activation in breast cancer cells, which was also validated in a large series of primary tumor samples. SRC activity suppression with dasatinib significantly prevented the in vitro functional effects of P-cadherin overexpressing cells, as well as their in vivo tumorigenic and metastatic ability, by increasing mice overall survival. Mechanistically, SRC inhibition affects P-cadherin downstream signaling, rescues the E-cadherin/p120-catenin complex to the cell membrane, recovering cell-cell adhesion function. CONCLUSIONS: In conclusion our findings show that targeting P-cadherin/SRC signaling and functional activity may open novel therapeutic opportunities for highly aggressive and poor prognostic basal-like breast cancer.This work was funded by Laço Grant 2014, by FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 – Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by FCT - Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Ensino Superior under the projects PTDC/SAU-GMG/120049/2010-FCOMP-01-0124-FEDER-021209, PEst-C/SAU/LA0003/2013, NORTE-01-0145-FEDER-000029 and POCI-01-0145-FEDER-016390. FCT funded the research grants of ASR (SFRH/BPD/75705/2011), ARN (SFRH/BD/100380/2014), BS (SFRH/BPD/104208/2014), AFV (SFRH/BPD/90303/2012), as well as JP with Programa IFCT 2013 (FCT Investigator). IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274)BMCRepositório da Universidade de LisboaRibeiro, Ana SofiaNobre, Ana RitaMendes, NunoAlmeida, JoãoVieira, André FilipeSousa, BárbaraCarvalho, Filomena AlmeidaMonteiro, JoanaPolónia, AntónioFonseca, MartinaSanches, João MiguelSantos, Nuno C.Seruca, RaquelParedes, Joana2019-03-27T12:04:21Z20182018-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/37707engCell Commun Signal. 2018 Nov 7;16(1):751478-811X10.1186/s12964-018-0286-2info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-11-20T17:49:20Zoai:repositorio.ul.pt:10451/37707Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-11-20T17:49:20Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells
title SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells
spellingShingle SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells
Ribeiro, Ana Sofia
P-cadherin
Dasatinib
Basal-like breast cancer
Src family kinase
title_short SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells
title_full SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells
title_fullStr SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells
title_full_unstemmed SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells
title_sort SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells
author Ribeiro, Ana Sofia
author_facet Ribeiro, Ana Sofia
Nobre, Ana Rita
Mendes, Nuno
Almeida, João
Vieira, André Filipe
Sousa, Bárbara
Carvalho, Filomena Almeida
Monteiro, Joana
Polónia, António
Fonseca, Martina
Sanches, João Miguel
Santos, Nuno C.
Seruca, Raquel
Paredes, Joana
author_role author
author2 Nobre, Ana Rita
Mendes, Nuno
Almeida, João
Vieira, André Filipe
Sousa, Bárbara
Carvalho, Filomena Almeida
Monteiro, Joana
Polónia, António
Fonseca, Martina
Sanches, João Miguel
Santos, Nuno C.
Seruca, Raquel
Paredes, Joana
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Ribeiro, Ana Sofia
Nobre, Ana Rita
Mendes, Nuno
Almeida, João
Vieira, André Filipe
Sousa, Bárbara
Carvalho, Filomena Almeida
Monteiro, Joana
Polónia, António
Fonseca, Martina
Sanches, João Miguel
Santos, Nuno C.
Seruca, Raquel
Paredes, Joana
dc.subject.por.fl_str_mv P-cadherin
Dasatinib
Basal-like breast cancer
Src family kinase
topic P-cadherin
Dasatinib
Basal-like breast cancer
Src family kinase
description © The Author(s). 2018. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
publishDate 2018
dc.date.none.fl_str_mv 2018
2018-01-01T00:00:00Z
2019-03-27T12:04:21Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/37707
url http://hdl.handle.net/10451/37707
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Cell Commun Signal. 2018 Nov 7;16(1):75
1478-811X
10.1186/s12964-018-0286-2
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BMC
publisher.none.fl_str_mv BMC
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817549038698889216